{"id":"W4389883767","doi":"10.1016/j.msard.2023.105329","title":"Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Bruton's tyrosine kinase; Open label; Term (time); Extension (predicate logic); Tyrosine kinase; Pharmacology; Oncology; Adverse effect; Internal medicine; Receptor; Cancer; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005304871,0.0006326127,0.002361171,0.0007596264,0.0003815321,0.002164963,0.001412509,0.001432706,0.004558809],"category_scores_gemma":[0.006351227,0.0002971732,0.002103287,0.001008059,0.0003808567,0.001882189,0.0005430215,0.003313695,0.001587921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001179208,"about_ca_system_score_gemma":0.00126662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001381157,"about_ca_topic_score_gemma":0.004318455,"domain_scores_codex":[0.9987118,0.0003281277,0.0003000457,0.0001184699,0.0004388968,0.00010267],"domain_scores_gemma":[0.9935901,0.003049467,0.001446365,0.0001899316,0.001438239,0.0002859352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01282423,0.0004770155,0.003497405,0.01044347,0.002112445,0.0003952051,0.0002173868,0.0008819777,0.007951813,0.0009992126,0.105835,0.8543647],"study_design_scores_gemma":[0.008962835,0.01014042,0.0313306,0.00778304,0.01109912,0.002993454,0.0002041719,0.0009958942,0.006051783,0.002737589,0.9175392,0.0001618272],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04552554,0.8899767,0.004781344,0.02355679,0.005023155,0.0004444013,0.01052915,0.0004881804,0.01967473],"genre_scores_gemma":[0.2192798,0.6606848,0.01093364,0.05730112,0.009901257,0.001112633,0.02661389,0.0003086177,0.01386437],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005304871,"threshold_uncertainty_score":0.02805519,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04704248551265507,"score_gpt":0.3317993253816995,"score_spread":0.2847568398690445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}